RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) — Capital Reinvestment Ratio
RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has a Capital Reinvestment Ratio of 0.55x as of December 2024, meaning it reinvests 1% of its operating cash flow (€127.60 Million) in capital expenditures (€70.40 Million). Check RHKU intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
RHOEN-KLINIK.UNSP.ADR 1/2 Capital Reinvestment Ratio (2021–2024)
This chart tracks RHOEN-KLINIK.UNSP.ADR 1/2's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see RHOEN-KLINIK.UNSP.ADR 1/2 operating cash flow efficiency.
Annual Capital Reinvestment Ratio for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)
Year-by-year Capital Reinvestment Ratio for RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024. See RHKU free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | €127.60 Million | €70.40 Million | ▼ -4.2% |
| 2023 | 0.58x | €109.00 Million | €62.80 Million | ▼ -40.3% |
| 2022 | 0.97x | €60.30 Million | €58.20 Million | ▲ +21.0% |
| 2021 | 0.80x | €97.50 Million | €77.80 Million | — |